IDEAYA Biosciences, Inc. - Common Stock (IDYA) stock analysis
IDYA · IDEAYA Biosciences, Inc. - Common Stock
Latest recorded price: USD 30.36
Sector and industry: Healthcare · Biotechnology
Fiscal 2025 figures: revenue growth 62.5%, free cash flow margin -33.6%, ROIC -68.3%. The model flags 2 risk signals for this company (1 high severity).